Scleroderma-like Syndrome in the Setting of Pembrolizumab Therapy for Non-Small Cell Lung Cancer: Diagnosis and Dermatologic Management.

Fattore, Davide; Battista, Teresa; De Lucia, Mario; Annunziata, Maria Carmela; Fabbrocini, Gabriella

Fattore, Davide; Battista, Teresa; De Lucia, Mario; Annunziata, Maria Carmela; Fabbrocini, Gabriella.

Afiliación

Fattore D; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Battista T; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
De Lucia M; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Annunziata MC; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Fabbrocini G; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

Case Rep Dermatol ; 14(2): 225-229, 2022.

Article en En | MEDLINE | ID: mdl-36158854

Palabras clave

Dermatologic management; Morphea; Non-small cell lung cancer; Pembrolizumab; Scleroderma-like syndrome

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Case Rep Dermatol Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google